Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleEffect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximab.AuthorsLee, Jeeyun; Hong, Yong; Hong, Jung; Han, Se; Kim, Tae; Kang, Hye; Kim, Kyu-pyo; Kim, Suk; Do, In-Gu; Kim, Kyoung-Mee; Sohn, Insuk; Park, Se; Park, Joon; Lim, Ho; Cho, Yong; Lee, Woo; Yun, Seong; Kim, Hee; Park, Young; Kang, WonPublicationInvestigational New Drugs, 2014, Vol 32, Issue 3, p535ISSN0167-6997Publication typeArticleDOI10.1007/s10637-014-0065-x